Next Article in Journal
Consumption Patterns of Alcohol and Alcohol mixed with Energy Drinks in Australian Students and Non-Students
Previous Article in Journal
Change in Diet Quality over 12 Years in the 1946–1951 Cohort of the Australian Longitudinal Study on Women’s Health
Previous Article in Special Issue
Heterozygotes Are a Potential New Entity among Homozygotes and Compound Heterozygotes in Congenital Sucrase-Isomaltase Deficiency
Open AccessReview

Low FODMAP Diet: Evidence, Doubts, and Hopes

1
Gastrointestinal Unit–Department of Translational Sciences and New Technologies in Medicine and Surgery, University of Pisa, 56124 Pisa, Italy
2
Clinical and Experimental Medicine–Rheumatology Unit, University of Pisa, 56100 Pisa, Italy
*
Author to whom correspondence should be addressed.
Nutrients 2020, 12(1), 148; https://doi.org/10.3390/nu12010148
Received: 13 November 2019 / Revised: 30 December 2019 / Accepted: 31 December 2019 / Published: 4 January 2020
Food is often considered to be a precipitating factor of irritable bowel syndrome (IBS) symptoms. In recent years, there has been a growing interest in FODMAPs (Fermentable Oligo-, Di-, Mono-saccharides, And Polyols), which can be found in many common foods. A low FODMAP diet (LFD) is increasingly suggested for IBS treatment. However, long-term, large, randomized controlled studies are still lacking, and certainties and doubts regarding LFDs have grown, often in a disorderly and confused manner. Some potential LFD limitations and concerns have been raised, including nutritional adequacy, cost, and difficulty in teaching the diet and maintaining it. Most of these limitations can be solved with the involvement of a skilled nutritionist, who can clearly explain the different phases of the LFD and ensure nutritional adequacy and compliance. Further studies should focus on new methods of teaching and learning the LFD and on predictors of response. Moreover, particular interest should be focused on the possible use of LFD in gastrointestinal diseases other than functional disorders and, possibly, also in non-gastrointestinal diseases. The aim of the present review was to clarify the effective and appropriate indications and limitations of an LFD and to discuss its possible future uses. View Full-Text
Keywords: irritable bowel syndrome; low FODMAP diet; nutrition; gut microbiota irritable bowel syndrome; low FODMAP diet; nutrition; gut microbiota
Show Figures

Figure 1

MDPI and ACS Style

Bellini, M.; Tonarelli, S.; Nagy, A.G.; Pancetti, A.; Costa, F.; Ricchiuti, A.; de Bortoli, N.; Mosca, M.; Marchi, S.; Rossi, A. Low FODMAP Diet: Evidence, Doubts, and Hopes. Nutrients 2020, 12, 148.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop